Lallemand Health Solutions welcomes applications from entities with scientifically documented strains for both traditional and innovative health applications
Lallemand Health Solutions announces the launch of Innov’Biome, an open innovation challenge inviting start-ups, companies, and research laboratories to participate throughout April and May 2025.
Morgane Maillard, Strategic development and open innovation manager at Lallemand Health Solutions, explains, “As we continue to explore the vast potential of microbiome-based solutions, we are seeking new probiotic strains, postbiotics, next-generation strains, and groundbreaking applications that can make a real impact on human health and nutrition. Collaboration has always been part of our DNA, and now we want to take it to the next level!”
Lallemand Health Solutions welcomes applications from entities with scientifically documented strains for both traditional and innovative health applications, for human health. The company is particularly interested in solutions for healthy ageing, women’s health, and gut health and remains open to receiving and analysing innovative biotic solutions in other health segments.
Mélanie Le Barz, Open innovation project manager and scientific advisor, adds, “While gastrointestinal health is still the main reason for probiotic use, new areas require high-quality research with trials tailored to specific populations, such as women and ageing individuals. Both market needs and science are evolving quickly, and we believe that biotic approaches are relevant to support health and quality of life.”
